<?xml version="1.0" encoding="utf-8"?>
<oembed>
  <version>1</version>
  <type>rich</type>
  <provider_name>Libsyn</provider_name>
  <provider_url>https://www.libsyn.com</provider_url>
  <height>90</height>
  <width>600</width>
  <title>Episode 1- Mobilisation in the ICU</title>
  <description>Summary For much of critical care history, immobility was the norm: patients were sedated, kept still, and “protected.” But decades of research have revealed the hidden costs — profound muscle wasting, delirium, and long-term disability. Jonathan explores how our understanding of mobilisation in ICU has evolved — from the recognition of harm caused by bedrest, to the first landmark studies proving that early movement is both feasible and beneficial. From Bedrest to Better: Why Mobilise in ICU?   ICU-acquired weakness: Patients can lose 15–20% of muscle mass within the first week of critical illness.   Long-term outcomes: ARDS survivors tracked for five years showed persistent disability and reduced independence.   Sedation &amp;amp;amp; delirium: Deep sedation increases delirium risk; mobilisation reduces both incidence and duration.   Physiological rationale: Even minimal movement supports cardiovascular tone, respiratory function, circulation, and cognition.   Core message: Bedrest is not neutral — it is actively harmful. Mobilisation offers protection for both brain and body.    Proof in Practice: The First Mobilisation Trials   Feasibility (Morris et al., 2008): Protocol-led mobilisation cut time to first mobilisation (5 vs 11 days), with no increase in adverse events.   Landmark RCT (Schweickert et al., 2009):   Early PT/OT + daily sedation interruption vs SAT alone.   59% vs 35% regained independence at discharge.   Patients had less delirium and spent fewer days ventilated.     Implementation (Needham et al.): Demonstrated how embedding mobilisation into daily ICU practice improves outcomes and serves as a model for quality improvement.   Core message: Early mobilisation is not only possible — it improves patient-centred outcomes safely.    Key Takeaways&amp;amp;nbsp;   Bedrest and heavy sedation accelerate weakness, delirium, and disability.   Mobilisation is both biologically plausible and clinically effective.   Early trials proved feasibility, safety, and functional benefits.   Success requires:   Lighter sedation targets and daily SATs.   Interdisciplinary teamwork (nursing, PT/OT, medical).   Structured protocols and safety screens.     Overall message: Mobilisation should no longer be an afterthought in ICU. It is a therapeutic intervention — one that supports recovery, preserves dignity, and helps patients walk out of intensive care with more than just survival. </description>
  <author_name>The Critical Care Practitioner</author_name>
  <author_url>http://criticalcarepractitioner.libsyn.com/website</author_url>
  <html>&lt;iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/38235665/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/88AA3C/" height="90" width="600" scrolling="no"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen&gt;&lt;/iframe&gt;</html>
  <thumbnail_url>https://assets.libsyn.com/secure/content/193103065</thumbnail_url>
</oembed>
